New Applications Data Demonstrates High Quality Peptide Synthesis
News Nov 26, 2008
Activotec has announced the availability of new applications data that demonstrates why the Activo-P11 Peptide Synthesizer is the peptide synthesizer of choice for a growing number of laboratories worldwide.
The Activo-P11 Peptide Synthesizer is an instrument for synthesis of very high quality peptides. The Activo-P11 offers the versatility to synthesize peptides of any length in the 0.1 - 2 mmoles scale in t-Boc or Fmoc chemistry, using any kind of activation.
Chris Littlewood, Chief Executive of Activotec, commented "Since its launch in 2007 - market reaction to the Activo-P11 has been extremely positive, installations in peptide laboratories worldwide have exceeded even our most optimistic expectations".
He added "We are the only European company with international service and support teams that are exclusively focused on peptide synthesis instrumentation and services. This enables Activotec to be uniquely positioned to provide customers with informed technical assistance enabling them to get the most from their peptide synthesizer".
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.